Influenza, HumanNCT02741843
Impact of Patient Education on Influenza Vaccine Uptake Among Community-dwelling Chinese Elderly
A study testing Patient Education in people with Influenza, Human, run by The University of Hong Kong.
Trial summary
The purpose of this study is to test the effectiveness of brief face-to-face patient education in increasing uptake of influenza vaccine among Chinese elderly in the community. Read more about this study
- Who is it for?
- Ages 65 years and olderHealthy volunteers can take part
- Conditions the study is for
- Influenza, Human
- What is being tested?
- Patient Education
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- Not given
- Where
- No sites listed yet
- Study dates
- Oct 2015to Nov 2015
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- Healthy volunteers accepted
- Older adult
Who may be able to join
- Cantonese speaking
- Chinese
Who cannot join
- cognitively impaired
- unable to communicate effectively
- having known contraindication of vaccination
- institutionalized
About this study
Official title: Impact of Patient Education on Influenza Vaccine Uptake Among Community-dwelling Chinese Elderly: A Randomised Controlled Trial
The purpose of this study is to test the effectiveness of brief face-to-face patient education in increasing uptake of influenza vaccine among Chinese elderly in the community.
- Conditions
- Influenza, Human
- Being tested
- Patient Education
- Medical subject headings
- Influenza, Human
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Patient EducationBehavioural
| Study group | Role | What they receive |
|---|---|---|
| Patient Education | Experimental | Not described Receives: Behavioral: Patient Education |
| Control | No intervention | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
proportion of patients receiving influenza vaccination
Measured: three working days
Secondary outcomes (3)
proportion of patients receiving influenza vaccination
Measured: five working days
proportion of patients receiving influenza vaccination
Measured: seven working days
proportion of patients receiving influenza vaccination
Measured: nine working days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Apr 2016 (estimated)
- Study startOct 2015
- Primary completionNov 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Influenza, HumanStudies of the same condition, open and under way.
- More trials run by The University of Hong KongThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
Sponsor and investigators
- Lead sponsor
- The University of Hong Kong
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02741843
- Sponsor's protocol ID
- HKUCTR-1930
- Status last verified
- May 2016
- First submitted
- 13 Apr 2016
- Last updated
- 6 May 2016
- Results posted
- No
Publications
Leung KC, Mui C, Chiu WY, Ng YY, Chen MHY, Ho PH, Kwok CP, Lam SSM, Wong CY, Wong KY, Pang HH. Impact of patient education on influenza vaccine uptake among community-dwelling elderly: a randomized controlled trial. Health Educ Res. 2017 Oct 1;32(5):455-464. doi: 10.1093/her/cyx053.
PubMed 28931164
Study at a glance
From the registry record, last updated by the sponsor on 6 May 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact of Patient Education on Influenza Vaccine Uptake Among Community-dwelling Chinese Elderly: A Randomised Controlled Trial
- ClinicalTrials.gov ID
- NCT02741843
- Acronym / sponsor ID
- HKUCTR-1930
- Conditions
- Influenza, Human
- Study type
- Interventional
- Recruitment status
- Completed
- Lead sponsor
- The University of Hong KongUniversity, hospital or other
- Study start
- Oct 2015
- Primary completion
- Nov 2015 (actual)
- First posted
- 18 Apr 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to test the effectiveness of brief face-to-face patient education in increasing uptake of influenza vaccine among Chinese elderly in the community.
Study design
- Primary purpose
- Health services research
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Patient Education | Experimental | Behavioral: Patient Education |
| Control | No intervention | – |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Older adult
Key inclusion criteria (2 listed)
- Cantonese speaking
- Chinese
Key exclusion criteria (4 listed)
- cognitively impaired
- unable to communicate effectively
- having known contraindication of vaccination
- institutionalized
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Patient Education | Behavioural | Patient Education |
Primary outcome
proportion of patients receiving influenza vaccination
Time frame: three working days
3 secondary outcomes
proportion of patients receiving influenza vaccination
Time frame: five working days
proportion of patients receiving influenza vaccination
Time frame: seven working days
proportion of patients receiving influenza vaccination
Time frame: nine working days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 May 2016.
- Derived from this study: PubMed 28931164Leung KC, Mui C, Chiu WY, Ng YY, Chen MHY, Ho PH, Kwok CP, Lam SSM, Wong CY, Wong KY, Pang HH. Impact of patient education on influenza vaccine uptake among community-dwelling elderly: a randomized controlled trial. Health Educ Res. 2017 Oct 1;32(5):455-464. doi: 10.1093/her/cyx053.
Related trials for Influenza, Human
Enrolling by invitation
Personalized Ventilator Settings for Patients on ECMO
Acute Respiratory Distress Syndrome (ARDS), Extracorporeal Membrane Oxygenation
RecruitingPhase 2
BPL-1357 Against H1N1 Influenza Virus Challenge
Influenza, Human
Not yet recruitingPhase 1
Safety and Immunogenicity of Chimeric Hemagglutinin mRNA Vaccine Candidates
Influenza
RecruitingPhase 1
pH1N1 Blinded Challenge Study
Influenza
RecruitingPhase 3
A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)
Influenza
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing Patient Education in people with Influenza, Human, run by The University of Hong Kong.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 May 2016. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
proportion of patients receiving influenza vaccination (time frame: three working days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02741843, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2016.